| 931 |
249: Production, Reactive oxygen species |
357: Cholestasis, Pathology |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 332 |
302: Production, VEGF-A |
301: Binding, VEGF-A |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 333 |
302: Production, VEGF-A |
304: Decreased, VegfR2 |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 69 |
57: Proliferation, Cell proliferation in the absence of cytotoxicity |
142: Hyperplasia, Hyperplasia |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1105 |
1067: Proliferation/Clonal Expansion, aberrant basal cells |
1068: squamous metaplasia, aberrant basal cells |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1082 |
1042: Proliferation/Clonal Expansion, smooth muscle |
1043: Hypertrophy/hyperplasia, smooth muscle |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 2540 |
1961: Prolongation of Action Potential |
1962: Prolongation of QT interval |
Dec 13, 2021 |
Dec 13, 2021 |
1 AOP
|
| 2541 |
1962: Prolongation of QT interval |
1963: Torsades de Pointes |
Dec 13, 2021 |
Dec 13, 2021 |
1 AOP
|
| 2853 |
1962: Prolongation of QT interval |
1106: Occurrence, cardiac arrhythmia |
Jan 29, 2023 |
Jan 29, 2023 |
None
|
| 2429 |
1842: TLR9 activation |
1897: MyD88 activation |
Jul 8, 2021 |
Jul 8, 2021 |
1 AOP
|
| 2433 |
1842: TLR9 activation |
1895: inflammasome activity, increased |
Jul 8, 2021 |
Jul 8, 2021 |
1 AOP
|
| 604 |
599: prolonged, Depolarization of neuronal membrane |
600: Overactivation, Neuronotransmitter release |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1098 |
1061: prolonged, elevation of serun CCK |
1062: Increased, Cellular proliferation / hyperplasia of acinar cells |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1111 |
1075: prolonged, estrus |
1076: Increased, circulating estrogen levels |
Nov 29, 2016 |
Dec 3, 2016 |
2 AOPs
|
| 1112 |
1075: prolonged, estrus |
1077: Increased, prolactin exposure |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 2829 |
1053: Promotion, ovarian adenomas |
2092: Promotion, Ovarian Cancer |
Jan 13, 2023 |
Mar 11, 2023 |
1 AOP
|
| 2830 |
1054: Promotion, ovarian granular cell tumors |
2092: Promotion, Ovarian Cancer |
Jan 13, 2023 |
Jan 13, 2023 |
None
|
| 1104 |
1066: Promotion, SIX-1 postive basal-type progenitor cells |
1067: Proliferation/Clonal Expansion, aberrant basal cells |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 240 |
211: Propagation, Oxidative stress |
131: Down Regulation, Gulcose-6-phosphate dehydrogenase |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 241 |
211: Propagation, Oxidative stress |
250: Damaging, Red blood cells; hemolysis |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 2912 |
2136: prostatic intraepithelial neoplasia |
2135: Prostate cancer |
May 11, 2023 |
May 11, 2023 |
1 AOP
|
| 1837 |
1585: Proteasomal dysfunction |
1586: Airway epithelial injury |
Jan 30, 2019 |
Jan 30, 2019 |
1 AOP
|
| 3044 |
1585: Proteasomal dysfunction |
1605: Accumulation, misfolded proteins |
Sep 14, 2023 |
Sep 14, 2023 |
1 AOP
|
| 1729 |
1509: Protein Adduct Formation |
1512: Unfolded Protein Response |
Apr 4, 2018 |
Apr 5, 2018 |
1 AOP
|
| 2679 |
2010: Pulmonary inflammation |
2008: Chronic obstructive pulmonary disease |
Jun 17, 2022 |
Jun 17, 2022 |
1 AOP
|